Oxford Biodynamics
OBD · AIM · Health Care · mcap £16m today, £16m on 27 Aug
Pattern evidence · every line sourced
- New CEO or CFO, 27 Aug: The appointment follows the Company's announcement of 30 June 2026 regarding Mr Compton's appointment as Chief Executive Officer and the completion of regulatory due diligence by the Company's Nomad. RNS
- Watch: next signal would be “Guidance cut” – “below expectations” or a profit warning, within 180 days.
AI summary with checked claims arrives with the nightly run. These lines are the matched extracts.
All announcements
-
27 Aug 26SIGNAL 1 New CEO or CFO
The appointment follows the Company's announcement of 30 June 2026 regarding Mr Compton's appointment as Chief Executive Officer and the completion of regulatory due diligence by the Company's Nomad.
Board Appointment · RNS 9742146 ↗
Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.